跳至主要内容
临床试验/NCT05006235
NCT05006235已完成1 期

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn

Ahmed Noaman0 个研究点目标入组 135 人开始时间: 2014年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
135
主要终点
Duration of oxygen support & O2 concentration until Downes' score less than 4

研究概览

简要总结

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn: Randomized controlled trial to assess:

详细描述

This is a randomized double-blind randomized controlled trial. It had been conducted at the Neonatal Intensive Care Unit (NICU) of Mansoura University Children's Hospital, Egypt Written informed consent had been taken from all parents whose infants were recruited in the study. The ethics committee of the faculty of medicine has approved the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Hour 至 6 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • babies with 35 weeks of gestation or more in the first 6 hours of life diagnosed with TTN according to the criteria of which are:
  • Tachypnea (respiratory rate exceeding 60 breaths/ min) within 6 hours after birth
  • Persistence of tachypnea for at least 12 hours
  • Mild cyanosis, nasal flaring, or retractions.
  • Chest radiograph indicating at least one of the following:
  • Prominent central vascular markings
  • Widened interlobar fissures
  • Symmetrical perihilar congestion
  • Hyperaeration is evidenced by flattening and depression of the diaphragmatic domes.

排除标准

  • Newborn infants with gestational age < 35 weeks
  • Meconium aspiration
  • Respiratory distress syndrome
  • Pneumonia
  • Congenital heart diseases including persistent pulmonary hypertension of the neworn (PPHN)
  • Sepsis or suspected sepsis
  • Polycythemia
  • Newborn infants with congenital malformations and chromosomal anomalies
  • Newborn infants with ventilatory support.
  • Newborn infants with arrhythmia

研究组 & 干预措施

Salbutamol Group

Active Comparator

included babies who had received nebulized B2 agonist salbutamol (0.15 mg/kg) + 4ml normal saline

干预措施: Salbutamol (Drug)

Epinephrine Group

Active Comparator

included babies who had received nebulized epinephrine (0, 05 ml/Kg) + 4ml normal saline

干预措施: Epinephrine Inhalation Solution (Drug)

Saline Group

Placebo Comparator

include babies who had received nebulized 0.9% saline

干预措施: Saline Inhalants (Drug)

结局指标

主要结局

Duration of oxygen support & O2 concentration until Downes' score less than 4

时间窗: through study completion, about 1 year

次要结局

  • Length of hospital stay until Downes' score less than 4(through study completion, about 1 year)
  • Effect of intervention on blood sugar (mg/dl)(within 12 hours after intervention)
  • Type of respiratory support (oxygen delivery and oxygen concentration)(within 12 hours after intervention)

研究者

发起方
Ahmed Noaman
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ahmed Noaman

Lecturer

Mansoura University Children Hospital

相似试验

Inhaled Beta-2 Agonist Versus Epinephrine For... | 临床试验